Paper Details

  1. Home
  2. Paper Details

Use of acetazolamide in lithium-induced nephrogenic diabetes insipidus: a case report.

Author: BravoPedro, FerreiraAna Gonçalves, MacauRicardo A, SilvaJoana Rego, da SilvaTiago Nunes

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study describes the case of a 63-year-old woman with bipolar disorder treated with lithium who developed severe dehydration after surgery and was diagnosed with lithium-induced nephrogenic diabetes insipidus (Li-NDI). Acetazolamide was successfully administered to control polyuria and hydroelectrolytic disorders without significant side effects. This is the third publication on acetazolamide use in Li-NDI patients.
Paper Details　
Original Abstract of the Article :
Lithium-induced nephrogenic diabetes insipidus (Li-NDI) is a rare and difficult-to-treat condition. A study in mice and two recent papers describe the use of acetazolamide in Li-NDI in 7 patients (a case report and a 6 patient series). We describe the case of a 63-year-old woman with bipolar disorde...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820740/

データ提供：米国国立医学図書館（NLM）

Acetazolamide: A Hidden Oasis in the Desert of Lithium-Induced Nephrogenic Diabetes Insipidus

Lithium-induced nephrogenic diabetes insipidus (Li-NDI), a rare and challenging oasis in the desert of health complications, can lead to severe dehydration and other problems. This study investigates the use of acetazolamide, a potential oasis in this desert of therapeutic challenges, to manage Li-NDI. The study presents a case report of a 63-year-old woman with Li-NDI who successfully responded to acetazolamide treatment, highlighting its potential as a treatment option for this condition.

Finding Relief in the Desert: Acetazolamide for Li-NDI

This case report provides a glimpse into the potential benefits of acetazolamide for managing Li-NDI. The study suggests that acetazolamide can effectively control polyuria and hydroelectrolytic disorders, offering a possible path to relief for patients suffering from this debilitating condition. However, further research is needed to confirm its efficacy and safety.

Navigating the Desert of Medication: Careful Monitoring

If you are taking lithium and experience any symptoms of Li-NDI, it's crucial to consult with your healthcare provider. Close monitoring and a personalized treatment plan are essential for navigating the desert of medication side effects and ensuring your safety and well-being.

Dr. Camel's Conclusion

This study offers a hopeful glimpse into the potential of acetazolamide for managing Li-NDI, a challenging oasis in the desert of health complications. While further research is needed to confirm its effectiveness, this study provides a reminder that even in the most desolate landscapes of health challenges, there can be hidden oases of hope and effective treatment options.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-03-16
Further Info :

Pubmed ID

29479446

DOI: Digital Object Identifier

PMC5820740

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.